BioCanna has a BioNano virus detection breakthrough
Nano technologies applied to make a low-cost, accurate test detection device for virus, inlcuding the one that cause COVID-19.
Trade deal will frustrate quest for COVID-19 vaccine
Industry’s rapid response is a reminder to support and protect biopharmaceutical innovation.
Pfizer to build new facility, add 450 jobs in Michigan
To spend $465 million building a new facility in Portage: production starting in 2024.
Police release cause of deaths of Barry and Honey Sherman
Apotex chief and wife died from ligature neck compression, deaths called suspicious.
Drug developers warn Ottawa that excessive cuts to prices could be harmful
They’re nervous about changes Health Canada will propose for the Patented Medicine Prices Review Board under a review.
Jean Coutu hopes a Quebec deal with drug makers will avoid tendering
Generic manufacturers fear lost business if others win exclusive rights to distribute blockbuster generic drugs.
Valeant sells cancer vaccine to China’s Sanpower Group for $819.9M
Quebec pharmaceutical will use the proceeds to permanently repay loan debts.
Valeant writes down Salix value, posts $1.22B loss
Revenue decline blamed on lower product sales, currency exchange rates and divestitures.
Eli Lilly and Co. plans $70M research facility expansion
Construction is expected to be completed in 2017.
Glaxo closes NC plant: Legionnaires bug discovered
Bacteria that causes a potentially fatal form of pneumonia found in cooling towers.
Health Canada yanks Canadadrugs.com’s licence
Concerned about manufacturing practices following inspection.
Chinese police accuse Brit GKS drugs exec of ordering bribes
First foreign employee of drugmaker to be accused in investigation announced last July.
Pharmaceutical giants to trade business units
And Novartis, GSK joint venture will focus on pain management, coughs, colds, dermatology.
Pfizer Inc. to close Peurto Rico manufacturing plant by 2017
Drug-maker says closure linked to loss of patent exclusivity and improved manufacturing efficiency.
Royal DSM to buy Canadian drugmaker Patheon for $195M
Deal combines chemical company to create larger independent drug manufacturer.